A coffee habit, a herbal supplement and a prescription medicine cannot be judged by the same yardstick. Yet online advice about fatty liver often puts them together as competing quick fixes.
In a September 23, 2026 Indian Express report, gastroenterologist Aabha Nagral rated six popular approaches. Those scores reflect her assessment, not a clinical trial comparing effectiveness or safety. The useful question is what evidence supports each claim.
Fatty liver means excess fat in the liver and can have different causes. The US National Institute of Diabetes and Digestive and Kidney Diseases notes that the metabolic form can have few or no symptoms. Its diagnostic guidance describes medical history, examination and tests. Body shape, cravings or tiredness cannot establish a diagnosis.
What the six claims can tell us
Liver tonics
“Liver tonic” is a marketing label, not one standardized treatment. The 2024 joint European liver, diabetes and obesity guidelines do not recommend nutraceuticals, including food supplements and herbal products, for metabolic fatty liver because evidence of effectiveness and safety is insufficient. A product needs evidence for its actual ingredients and intended use.
Coffee
The same guidelines describe associations between coffee consumption and better liver outcomes in observational studies. An association does not prove that coffee caused the benefit or that it will treat an individual's condition. A favourable score is not a prescription to start drinking it.
Resistance exercise
Weight lifting belongs within a broader discussion of physical activity. NIDDK's treatment guidance says activity can be beneficial even without weight loss. The European guidelines recommend exercise tailored to ability, while noting that evidence for scarring and long-term liver outcomes is less robust. That distinction does not justify promising that heavy lifting reverses disease.
Detox teas
The US National Center for Complementary and Integrative Health's review of detox programmes finds limited, generally low-quality research. Some programmes involve laxatives that can cause diarrhoea and dehydration. This supports caution about detox claims; it does not establish that every herbal tea is harmful.
GLP-1 medicines
These are prescription treatments, not interchangeable wellness hacks. The US FDA approved Wegovy semaglutide injections for adults with MASH and moderate-to-advanced liver scarring, without cirrhosis, through accelerated approval. MASH is an inflammatory form of metabolic fatty liver disease. Further data must confirm meaningful longer-term benefit. This specific US decision neither applies to every GLP-1 medicine nor establishes approval or suitability in India.
Ashwagandha
NCCIH's ashwagandha fact sheet reports limited evidence for many promoted uses and rare cases linking supplements to liver injury. It does not establish ashwagandha as a fatty-liver treatment. A natural origin does not settle questions about safety, interactions or benefit.
A rating cannot choose a treatment
These six items involve different kinds of evidence, different risks and different clinical decisions. A clinician's assessment of the cause and stage of liver disease matters more than an online score. Discuss supplements and treatment decisions with a qualified healthcare professional rather than using a viral ranking as a personal care plan.
